Relenza Générique est utilisé pour traiter les symptômes de la grippe causée par le virus influenza chez les patients qui ont des symptômes depuis moins de 2 jours. Ce médicament peut également être administré afin de prévenir l'influenza chez les gens qui peuvent y être exposé mais qui ne montrent pas de symptômes. Ce médicament ne traite pas le rhume.
Liquidia touts promise of next-gen respiratory delivery - FierceDrugDelivery
Liquidia touts promise of next-gen respiratory deliveryFierceDrugDeliveryIn one study, researchers took the API zanamivir and crafted a molecule with PRINT.
Study: H1N1 resistance to oseltamivir may spread - CIDRAP
Study: H1N1 resistance to oseltamivir may spreadCIDRAP.
Theraclone Passes First Clinical Test with Flu-Fighting Antibody - Xconomy
XconomyTheraclone Passes First Clinical Test with Flu-Fighting AntibodyXconomyWhile there are already a couple of antiviral pills on the market—Roche's oseltamivir phosphate (Tamiflu) or GlaxoSmithKline's zanamivir (Relenza)—scientists worry about mutant strains like H5N1 “bird flu” that could emerge and resist today's .
Ready, set, trial: why pandemics catch us out and how to prepare for them - Discover Magazine (blog)
Discover Magazine (blog)Ready, set, trial: why pandemics catch us out and how to prepare for themDiscover Magazine (blog)Tamiflu's relatives, zanamivir and peramivir, are similarly mysterious.
Biota Announces Inavir(R) Royalty Results for Q312 and Phase III Prevention ... - MarketWatch (press release)
Biota Announces Inavir(R) Royalty Results for Q312 and Phase III Prevention .